Agrify Announces Record Revenue Results for First Quarter 2022
First Quarter Revenue Grew 271% Year-Over-Year to
First Quarter Contractual Backlog Increased by
"Increased customer adoption across our product lines not only fueled our Q1 growth but also helped strengthen the foundation for future high-margin recurring revenue streams, which we expect to begin to realize later this year," said
First Quarter 2022 Financial Results
- Revenue was
$26.0 million for the first quarter, an increase of 271% compared to$7.0 million for the prior year period. - Gross profit for the first quarter totaled
$4.2 million , or 16.0% of revenue, compared to$(540) thousand , or (7.7)% of revenue, in the prior year period. - Operating expenses were
$13.9 million for the first quarter, compared to$6.0 million in the prior year period. The comparative increase in the first quarter operating expenses is largely attributable to overall growth in the scale of the Company’s core business and recent acquisitions, increases in amortization expense associated with the intangible assets identified as part of the Company’s recently completed acquisitions, direct acquisition-related costs, an investment banker termination fee, and restructuring charges. - Net loss for the first quarter was
$8.9 million , or$0.36 per diluted share, compared to net loss of$3.8 million , or$0.33 per diluted share, in the prior year period. - Cash flow used in operating activities was
$34.2 million for the first quarter, compared to$7.3 million in the prior year period. First quarter 2022 cash flows used in operating activities related to the increase in inventory associated with the current and future construction of the Company’s VFUs, current quarter operating performance, first quarter renewals of insurance policies, and the capitalization of debt issuance costs. - Adjusted EBITDA (a non-GAAP financial measure) was a loss of
$6.1 million in the first quarter (see “Non-GAAP Financial Measures” below for further discussion of this non-GAAP term, including a reconciliation to the most comparable GAAP measure), compared to a loss of$4.2 million in the prior year period.
Recent Business Highlights
- On
May 10, 2022 ,Agrify announced a$2 million agreement withMichigan -basedBoone Labs to outfit its new production facility with the complete range ofAgrify offerings including 72 VFUs powered by the Agrify Insights™ software, as well as solventless extraction, hydrocarbon extraction, and ice water hash washing solutions. Boone Labs will be the first customer to leverage Agrify’s full suite of offerings, across cultivation, extraction, and consumer brands, to create a fully operational cannabis production business. - On
May 6, 2022 ,Agrify announced the launch of the PX5 product from its Extraction Division, expanding its portfolio of industry-leading processing solutions with its latest, most advanced and scalable passive hydrocarbon extractor. The PX5’s unique passive recovery design offers immediate economic benefits to cannabis operators of any size with projected benefits including an increase in daily production of up to 33%, savings in annual energy costs of up to 40%, and an increase in hourly extract production of 200% to 300% with specialized training available from Agrify Extraction. - On
April 20, 2022 ,Agrify announced the launch of its VFU Rapid Deployment Packs, which allow cultivators to accelerate their speed to market and streamline VFU adoption for multi-state operators (“MSOs”) without requiring major building renovations that cause disruptions to existing operations. - On
April 13, 2022 ,Agrify announced its VFU sales agreement with BioCann Pharmaceutical, a prominent cannabis cultivator in Madeira,Portugal . The agreement will introduce the Company’s VFU technology intoEurope , one of the largest cannabis markets in the world with high and stringent quality and safety requirements. The agreement includes the purchase of 190 VFUs and$2.3 million in estimated SaaS fees. - On
April 11, 2022 ,Agrify announced it had entered into an Agrify Total Turn-Key Solution (“Agrify TTK Solution”) partnership with Loud Wellness, a licensedNew Jersey -based cultivation and manufacturing operator. The partnership, which includes the installation of 500 VFUs, is expected to generate approximately$118 million of estimated total revenue forAgrify over the full 10-year term of the agreement, of which$100 million is estimated to be from production success fees and$18 million is estimated to be from SaaS fees. - On
April 6, 2022 ,Agrify announced its VFU sales agreement with Greenlight Cannabis (“Greenlight”), a prominent and rapidly growing MSO inthe United States with 28 locations across 5 states. Under the agreement, the Company plans to install VFUs that will enable Greenlight to increase its grow canopy in order to achieve rapid business growth and geographic expansion under one standard.
About Agrify TTK Solution
The Agrify TTK Solution is a first-of-its-kind program in which
VFU Backlog
2022 Outlook
Conference Call and Webcast Information
All interested parties are invited to listen to the live conference call by dialing the number below or by clicking the webcast link, which can be accessed by visiting Agrify’s Investor Relations website at ir.agrify.com and navigating to the Events page. The Company has also posted an accompanying slide presentation, which can be found in the same location as the webcast link.
- DATE:
Wednesday, May 11, 2022 - TIME:
8:30 a.m. ET - WEBCAST (live and available for replay): https://ir.agrify.com/news-and-events/investor-calendar
- DIAL-IN NUMBER: (844) 792-4409
- CONFERENCE ID: 2387725
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning
AGRIFY CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Operations
(In thousands, except for per share amounts)
(Unaudited)
Three Months Ended |
||||||||
2022 | 2021 | |||||||
Revenue | $ | 26,021 | $ | 7,008 | ||||
Cost of goods sold | 21,851 | 7,548 | ||||||
Gross profit | 4,170 | (540 | ) | |||||
General and administrative | 9,759 | 4,458 | ||||||
Sales and marketing | 2,090 | 616 | ||||||
Research and development | 2,084 | 882 | ||||||
Total operating expenses | 13,933 | 5,956 | ||||||
Loss from operations | (9,763 | ) | (6,496 | ) | ||||
Interest income (expense), net | 682 | (32 | ) | |||||
Gain on extinguishment of notes payable | - | 2,685 | ||||||
Other income, net | 682 | 2,653 | ||||||
Net loss before income taxes | (9,081 | ) | (3,843 | ) | ||||
Income tax benefit | (200 | ) | - | |||||
Net loss | (8,881 | ) | (3,843 | ) | ||||
Income (loss) attributable to non-controlling interest | 1 | (33 | ) | |||||
Net loss attributable to |
$ | (8,882 | ) | $ | (3,810 | ) | ||
Net loss per share attributable to common | ||||||||
stockholders – basic and diluted | $ | (0.36 | ) | $ | (0.33 | ) | ||
Weighted average commons shares | ||||||||
outstanding – basic and diluted | 24,589 | 11,568 |
AGRIFY CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
2022 | 2021 | ||||||
Assets | (Audited) | ||||||
Cash and cash equivalents | $ | 25,205 | $ | 12,014 | |||
Restricted cash | 30,000 | - | |||||
Marketable securities | 38,211 | 44,550 | |||||
Accounts receivable, net | 8,571 | 7,222 | |||||
Inventory | 38,989 | 20,498 | |||||
Prepaid expenses and other assets | 6,567 | 2,452 | |||||
Total current assets | 147,543 | 86,736 | |||||
Loan receivable, net | 34,738 | 22,255 | |||||
Property and equipment, net | 7,055 | 6,232 | |||||
Right-of-use assets, net | 1,554 | 1,479 | |||||
70,405 | 64,162 | ||||||
Other non-current assets | 3,180 | 1,184 | |||||
Total assets | $ | 264,475 | $ | 182,048 | |||
Liabilities | |||||||
Accounts payable | $ | 3,683 | $ | 9,151 | |||
Accrued expenses and other current liabilities | 30,112 | 28,764 | |||||
Operating lease liabilities, current | 911 | 814 | |||||
Long-term debt, current | 2,970 | 1,089 | |||||
Deferred revenue | 4,182 | 3,772 | |||||
Total current liabilities | 41,858 | 43,590 | |||||
Other non-current liabilities | 275 | 318 | |||||
Deferred tax liabilities, net | 62 | - | |||||
Operating lease liabilities, non-current | 689 | 704 | |||||
Long-term debt | 51,154 | 12 | |||||
Total liabilities | 94,038 | 44,624 | |||||
Stockholders’ Equity | |||||||
Common stock | 25 | 21 | |||||
Preferred stock | - | - | |||||
Additional paid-in capital | 237,903 | 196,013 | |||||
Accumulated deficit | (67,857 | ) | (58,975 | ) | |||
Total stockholders’ equity | 170,071 | 137,059 | |||||
Non-controlling interests | 366 | 365 | |||||
Total liabilities and stockholders’ equity | $ | 264,475 | $ | 182,048 |
AGRIFY CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statement of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended |
|||||||
2022 | 2021 | ||||||
Cash flow (used in) provided by: | |||||||
Operating activities | $ | (34,171 | ) | $ | (7,279 | ) | |
Investing activities | (13,365 | ) | (142 | ) | |||
Financing activities | 90,727 | 137,197 | |||||
Net increase in cash, cash equivalents and restricted cash | $ | 43,191 | $ | 129,776 |
Non-GAAP Financial Measures
To supplement our financial information presented in accordance with generally accepted accounting principles in
We calculate Adjusted EBITDA as net loss adjusted to exclude (i) tax provision and benefit; (ii) interest income and expense, net; (iii) other income and expense, net; (iv) depreciation and amortization, (v) stock-based compensation expense, (vi) acquisition-related expenses; (vii) investment banker termination fees; (viii) restructuring charges; (ix) gains and losses associated with the extinguishment of debt; (x) changes in derivative liabilities; (xi) changes in contingent consideration; (xii) gain associated with the forgiveness of PPP loans; and (xiii) other items affecting our results that we do not view as representative of our ongoing operations, including losses associated with write-offs.
We believe Adjusted EBITDA is a commonly used by investors to evaluate our performance and that of our competitors. However, our use of the term Adjusted EBITDA may vary from that of others in our industry. Adjusted EBITDA should not be considered as an alternative to net loss before taxes, net loss, loss per share or any other performance measures derived in accordance with
Adjusted EBITDA has important limitations as an analytical tool and you should not consider it in isolation or as a substitute for analysis of our results as reported under
In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Adjusted EBITDA should not be considered as an alternative to loss before benefit from income taxes, net loss, earnings per share, or any other performance measures derived in accordance with
The following table presents a reconciliation of Adjusted EBITDA from the most comparable GAAP measure, net loss, for the three months ended
AGRIFY CORPORATION AND SUBSIDIARIES
Reconciliation of GAAP Net Loss to Non-GAAP Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended |
|||||||
2022 | 2021 | ||||||
Net loss | $ | (8,882 | ) | $ | (3,810 | ) | |
Add: | |||||||
Income tax benefit | (200 | ) | - | ||||
Interest (income) expense | (682 | ) | 32 | ||||
Depreciation and amortization | 1,052 | 147 | |||||
Stock-based compensation | 953 | 2,135 | |||||
Direct acquisition expenses | 637 | - | |||||
Investment banker termination fees | 637 | - | |||||
Restructuring charges | 387 | - | |||||
Gain on extinguishment of notes payable | - | (2,685 | ) | ||||
Adjusted EBITDA | $ | (6,098 | ) | $ | (4,181 | ) |
Company Contacts
Agrify
Timothy Oakes
Chief Financial Officer
tim.oakes@agrify.com
(781) 760-7512
Investor Relations Inquiries
Anna Kate Heller
ICR
agrify@icrinc.com
Media Inquiries
MATTIO Communications
agrify@mattio.com
Source: Agrify